These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 10561944)
21. [HIV-1 transmission from mother to child and its prevention]. Le Coeur S; Kanshana S; Jourdain G Med Trop (Mars); 2003; 63(4-5):381-90. PubMed ID: 14763292 [TBL] [Abstract][Full Text] [Related]
22. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States. American Academy of Pediatrics Committee on Pediatric AIDS Pediatrics; 2008 Nov; 122(5):1127-34. PubMed ID: 18977995 [TBL] [Abstract][Full Text] [Related]
23. Maternal and umbilical cord serum zidovudine levels in human immunodeficiency virus infection. Phuapradit W; Sirinavin S; Taneepanichskul S; Chaovavanich A; Wiratchai A; Sunthornkachit R; Puchaiwatanon O Aust N Z J Obstet Gynaecol; 1998 Aug; 38(3):288-92. PubMed ID: 9761155 [TBL] [Abstract][Full Text] [Related]
24. Mother to child transmission of HIV-1 in a Thai population: role of virus characteristics and maternal humoral immune response. Kittinunvorakoon C; Morris MK; Neeyapun K; Jetsawang B; Buehring GC; Hanson CV J Med Virol; 2009 May; 81(5):768-78. PubMed ID: 19319941 [TBL] [Abstract][Full Text] [Related]
25. Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa. Coetzee D; Hilderbrand K; Boulle A; Draper B; Abdullah F; Goemaere E Bull World Health Organ; 2005 Jul; 83(7):489-94. PubMed ID: 16175822 [TBL] [Abstract][Full Text] [Related]
26. Incremental cost-effectiveness of two zidovudine regimens to prevent perinatal HIV transmission in the United States. Pinkerton SD; Holtgrave DR; Layde PM Prev Med; 2000 Jan; 30(1):64-9. PubMed ID: 10642461 [TBL] [Abstract][Full Text] [Related]
27. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV. Palombi L; Marazzi MC; Voetberg A; Magid NA AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755 [TBL] [Abstract][Full Text] [Related]
28. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach. Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983 [TBL] [Abstract][Full Text] [Related]
29. [Mother-to-child transmission of HIV infections. Antiviral agents and Cesarean section reduce the risk of transmission]. Bohlin AB; Lindgren S; Lidman K; Sönnerborg A Lakartidningen; 2000 Jul; 97(28-29):3275-9. PubMed ID: 10997016 [TBL] [Abstract][Full Text] [Related]
30. Genotypic resistance tests for the management of the HIV-infected pregnant woman. Bassetti D; Cargnel A Scand J Infect Dis Suppl; 2003; 106():70-4. PubMed ID: 15000589 [TBL] [Abstract][Full Text] [Related]
31. Mother-to-child transmission of HIV-1: advances and controversies of the twentieth centuries. Scarlatti G AIDS Rev; 2004; 6(2):67-78. PubMed ID: 15332429 [TBL] [Abstract][Full Text] [Related]
32. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1? Galli L; Puliti D; Chiappini E; Gabiano C; Ferraris G; Mignone F; Viganò A; Giaquinto C; Genovese O; Anzidei G; Badolato R; Buffolano W; Maccabruni A; Salvini F; Cellini M; Ruggeri M; Manzionna M; Bernardi S; Tovo P; de Martino M; Clin Infect Dis; 2009 May; 48(9):1310-7. PubMed ID: 19309307 [TBL] [Abstract][Full Text] [Related]
33. [Human immunodeficiency virus infection in pregnant women. The importance of recognizing the infection during pregnancy and risk factors for perinatal transmission]. Ovalle A; Vizueta E; Casals A; Northland R; González R; Labbe E Rev Med Chil; 2003 Jun; 131(6):633-40. PubMed ID: 12942591 [TBL] [Abstract][Full Text] [Related]
34. Global strategies for the prevention of vertical HIV transmission. MacDougall DS J Int Assoc Physicians AIDS Care; 1997 Dec; 3(12):18-27. PubMed ID: 11364942 [TBL] [Abstract][Full Text] [Related]
35. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update. Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650 [TBL] [Abstract][Full Text] [Related]
37. Maternal serum vitamin A levels are not associated with mother-to-child transmission of HIV-1 in the United States. Burger H; Kovacs A; Weiser B; Grimson R; Nachman S; Tropper P; van Bennekum AM; Elie MC; Blaner WS J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Apr; 14(4):321-6. PubMed ID: 9111473 [TBL] [Abstract][Full Text] [Related]
38. [Preliminary study on the transport of AZT (Retrovir-zidovudine) through the placenta]. Gillet JY; Bongain A; Abrar D; Garraffo R; Lapalus P J Gynecol Obstet Biol Reprod (Paris); 1990; 19(2):177-80. PubMed ID: 2324439 [TBL] [Abstract][Full Text] [Related]
39. Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants. Rodman JH; Flynn PM; Robbins B; Jimenez E; Bardeguez AD; Rodriguez JF; Blanchard S; Fridland A J Infect Dis; 1999 Dec; 180(6):1844-50. PubMed ID: 10558940 [TBL] [Abstract][Full Text] [Related]
40. Zidovudine pharmacokinetics during pregnancy. Sperling RS; Roboz J; Dische R; Silides D; Holzman I; Jew E Am J Perinatol; 1992 Jul; 9(4):247-9. PubMed ID: 1627212 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]